66 Review Article An Overview of Glaucoma Diagnosis Management A Literature Review Eilaf Khaled Alsirhani Sahli Abdulaziz Ali Y Saad Mutlaq Ayidh Alosaimi Samaa Ahmed Ali Alkhawajah Saja Kha ID: 958787
Download Pdf The PPT/PDF document "2020 Archives of Pharmacy Practice" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
2020 Archives of Pharmacy Practice 66 Review Article An Overview of Glaucoma Diagnosis & Management: A Literature Review Eilaf Khaled Alsirhani, Sahli Abdulaziz Ali Y, Saad Mutlaq Ayidh Alosaimi, Samaa Ahmed Ali Alkhawajah, Saja Khalifah AlsaqerMohammed Samry H Alanazi, Huda Oawid Hedmool Alanzi, Linah Saleh Abbas Alghamdi, Abdulaziz Salman Alfaifi, Jehan Abdulrahman Almutairi8 Faculty of Medicine, Tabuk University, Tabuk, KSAFaculty of Medicine, Jazan University, Jazan, KSAFaculty of Medicine, Shaqra University, Shaqra, KSAFaculty of Medicine, King Faisal University, Al Ahsa, KSAFaculty of Medicine, Northern Border University, Skkaka, KSAFaculty of Medicine, Al Baha University, Al Baha, KSA.Faculty of Medicine, King Khalid University, Abha, KSAFaculty of Medicine, Dar Al-Uloom University, Riyadh, KSA. Abstract Introduction: Glaucoma a leading cause of irreversible visual impairment worldwide and diagnosis frequently delayed. Although the pathogenesis of glaucoma not fully understood, incidence increases with age, the patients often have numerous comorbidities and use various medications. Thus, management and understanding of this disease. Objective: aimed review the literature reviewing the pathophysiology, clinical features, risk factors, diagnosis, and management of glaucoma.Methodology: Pubmed was used select eligible articles using these terms Mesh ³ * O D X F R P D ´ "Glaucoma S D W K R S K \ V L R O R J \ ´Glaucoma trials ³ * O D X F R P D management and G L D J Q R V L V ´ within the title abstract. Conclusion: Glaucoma is a leading cause of blindness worldwide so it requires accurate evaluation of the stages and progression of the diseases in order to detect the possible ways of management. Management of decision making demands solid history, detailed investigations, and cautious follow-up.Keywords: Glaucoma, Pathophysiology, Management, Diagnosis. NTRODUCTION Glaucoma a worldwide leading cause irreversible visual impairment and diagnosis frequently delayed [1]. Glaucoma currently defined a characteristic progressive degeneration the optic nerve, characterized the loss retinal ganglion cells, thinning the retinal nerve fiber layer, which may also lead specific visual field defects over time . Although the pathogenesis glaucoma not fully understood, the incidence glaucoma increases with age, the patients often have numerous comorbidities and use various medications [3]. Moreover, increased intraocular pressure (IOP) the most significant risk factor glaucoma.. It has been shown that the reduction intraocular pressure only proven method effectively treat the disease. This can usually achieved anti-glaucoma medications, laser therapy, surgical intervention. However, the role complementary and alternative medical management glaucoma has received great interest from patients and ophthalmologists. 5] This review based previously conducted studies and a general understandi the disease, pathophysiology, risk factors, clinical features, and management. ETHODOLOGY: PubMed database was used for articles selection, and the following keys were used the ³ * O D X F R P D "[Mesh] ³ ' L D J Q R V L V "[Mesh] AND ³ &